Abstract
The pharmaceutical company has two different types that are the large pharmaceutical firm and bio-pharmaceutical firm. First of all, the large pharmaceutical firm is founded by a specialist in chemistry, but later it changes the type of company from chemical firm to pharmaceutical firm. Secondly, the bio-pharmaceutical firm has more powerful biotechnology abilities. Meanwhile, it is used by the technology for drug development, become a pharmaceutical company based on biotechnology. With rapid of development of biotechnology, the structure of pharmacy will be changed by biotech. Most of large pharmaceutical companies like Pfizer were chemical company. It had been developing the drug thought the biotechnology. Nowadays the biotechnology emergence, the time for drug discovery becomes shorter, that is biotechnology more efficient than combinational chemistry for the drug development and drug compound searching, and the biotechnology with DNA recombination makes the process of drug screening become quicker. The technology in biotech is changing everyday; even it is faster than chemistry. Namely, compared with the biotech firm, the large pharmaceutical company which concentrated on the R&D of new drug is not completed in the technology of drug developing, but most of time the biotech company is focused on the R&D of biotechnology, and how to become faster in drug screening through the biotechnology. In the past the times for developing a new drug require 12 years, but the pattern has only 20 years to support the new drug cannot be clone other firms. On the other hand, the firm will spends 3 years to cover all of the drug developing costs with new drug benefits, in other words, the time that can profits from new drug is only 5 years. If the biotechnology can provide the more active method for drug screening, that can be more efficient in process of R&D, which can let the pharmaceutical firm has more time to makes returns. The large pharmaceutical firm can improve its new drug performance if it can build up the alliance with biotech firm. For these reasons, the thesis will focus on the two varied types of pharmaceutical company that the influence on the performance of new drugs after pharmaceutical alliances. The other hand, the information about the whole market of pharmaceutical industry will show detail in this thesis. Finally, we will have the case study with Pfizer which is most famous large pharmaceutical firm, through Pfizer to know the tendency of pharmacy, and then have some suggestions for Taiwan’s pharmaceutical company. Keywords: biotechnology, pharmaceutical, pharmacy, new drug, alliance